hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06289855, orgStudyIdInfo id: Parkinson's disease, briefTitle: Impulse Control Disorder Among Parkinson's Disease Patients, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2024-08-31, completionDateStruct date: 2025-03-31, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-08, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: The goal of this observational study is to learn about impulse control disorders in Parkinson's disease patients.The main question: it aims to answer:* Detect Relative frequency of impulse control disorder among Parkinson's disease patients* Detect Relation between impulse control disorders, and other non motor and motor symptoms in Parkinson's disease patients, using clinical, neurophysiological and radiological assessment, conditionsModule conditions: Parkinson's Disease, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 56, type: ESTIMATED, armsInterventionsModule interventions name: MDS-UPDRS, outcomesModule primaryOutcomes measure: number of patients with impulse control disorder among Parkinson's disease patients, secondaryOutcomes measure: percent of cognition affection, gait affection among patients with impulse control disorder among Parkinson's disease patients, secondaryOutcomes measure: volume of cortex and basal ganglia in patients with impulse control disorder among Parkinson's disease patients, secondaryOutcomes measure: cortical excitability and inhibition inpatients with impulse control disorder among Parkinson's disease patients, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06289842, orgStudyIdInfo id: ZU-IRB #9697, briefTitle: Accelerated Theta Burst Stimulation for Treatment of Suicidality in Depressed Patients, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-01, primaryCompletionDateStruct date: 2025-01, completionDateStruct date: 2026-01, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Zagazig University, class: OTHER_GOV, descriptionModule briefSummary: The objective of this study is to investigate efficacy of accelerated theta burst stimulation (TBS) in suicidal reduction in patients with unipolar and bipolar depression, conditionsModule conditions: Suicide and Depression, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 34, type: ESTIMATED, armsInterventionsModule interventions name: Transcranial Magnetic Stimulation MagPro R30 with the MCF-B70 figure-of-eight coil (MagVenture, Denmark), outcomesModule primaryOutcomes measure: Change in suicidal ideation and behaviors as measured by Columbia Suicide Severity Rating Scale (C-SSRS), secondaryOutcomes measure: Change from baseline Montgomery-Åsberg Depression Rating Scale (MADRS) Score, eligibilityModule sex: ALL, minimumAge: 19 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Zagazig University, status: RECRUITING, city: Zagazig, zip: 44519, country: Egypt, contacts name: Medhat M Bassiony, Professor, role: PRINCIPAL_INVESTIGATOR, contacts name: Usama M Youssef, Professor, role: SUB_INVESTIGATOR, contacts name: Ghada M Salah El-Deen, Professor, role: SUB_INVESTIGATOR, contacts name: Hayam M El-Gohary, Professor, role: SUB_INVESTIGATOR, contacts name: Alaa E Zayed, Ass.Lecturer, role: SUB_INVESTIGATOR, geoPoint lat: 30.58768, lon: 31.502, hasResults: False
protocolSection identificationModule nctId: NCT06289816, orgStudyIdInfo id: 28/01/2023, briefTitle: Spleen Preserving Surgery for Splenic Hydatidosis: A Cohort Study on Short and Long-Term Outcomes, statusModule overallStatus: COMPLETED, startDateStruct date: 2015-01-01, primaryCompletionDateStruct date: 2021-06-30, completionDateStruct date: 2021-06-30, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Yarmouk University, class: OTHER, descriptionModule briefSummary: This retrospective cohort study examines the effectiveness of minimally invasive spleen-preserving surgeries compared to total splenectomy for treating primary splenic hydatidosis in Jordan. Covering 18 patients from January 2015 to June 2021, the research highlights similar recurrence rates between both surgical approaches, emphasizing the benefits of spleen preservation in maintaining immune function and reducing septic risks, particularly in pediatric patients., conditionsModule conditions: Spleen-Preserving Surgery, conditions: Echinococcus Granulosus Infection, conditions: Hydatid Disease, conditions: Minimally Invasive Surgery, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 18, type: ACTUAL, armsInterventionsModule interventions name: Minimally Invasive Surgery, outcomesModule primaryOutcomes measure: Incidence of Postoperative Short-Term Complications, primaryOutcomes measure: Incidence of Postoperative Long-Term Complications, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Anas Aljaiuossi, city: Irbid, zip: 22110, country: Jordan, geoPoint lat: 32.55556, lon: 35.85, hasResults: False
protocolSection identificationModule nctId: NCT06289803, orgStudyIdInfo id: Huadong Hospital of FudanU, briefTitle: The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-09-01, primaryCompletionDateStruct date: 2025-01-31, completionDateStruct date: 2025-06-30, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Fudan University, class: OTHER, descriptionModule briefSummary: Aim of the study: To evaluate the value of Probe Confocal Laser Endomicroscopy (PCLE) in surgery for pancreatic tumor.Methods:Patients who are diagnosed with pancreatic tumor based on preoperative radiographic findings and will undergo radical resection are included in this clinical study. PCLE will be used in surgery to identify tumor is malignant or not, and surgeons will decide procedures of surgery based on outcomes of PCLE. In this present study, clinical trials will be divided into two phases. In the first phase, based on the definitive postoperative pathologic diagnosis, characteristic imaging structures that were collected by PCLE will be identified and primary diagnostic imaging criteria for pancreatic cancer would be developed. In the second phase, this criterion will be used for rapid intraoperative diagnosis of pancreatic cancer and predicting status of resection margin. In addition, accuracy of PCLE will be verified based on postoperative pathologic reports., conditionsModule conditions: Pancreatic Cancer, conditions: Diagnosis, conditions: Pancreatoduodenectomy, conditions: Distal Pancreatectomy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: Patients diagnosed with pancreatic tumours will undergo surgical resection, and PCLE will be used for identifying the behaviour of tumours (benign or malignant neoplasms) and predicting the status of resection margin., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 200, type: ESTIMATED, armsInterventionsModule interventions name: probe confocal laser endomicroscopy, outcomesModule primaryOutcomes measure: diagnostic efficacy, secondaryOutcomes measure: Rate of R0 resection, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 90 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Huadong Hospital affiliated to Fudan University, status: RECRUITING, city: Shanghai, state: Shanghai, zip: 200040, country: China, contacts name: Chunjing Li, M.S, role: CONTACT, phone: 14790068967, email: Lcj1479006@163.com, contacts name: Chongyi Jiang, M.D, role: CONTACT, phone: +8618101802916, email: jiangzhongyi9@126.com, geoPoint lat: 31.22222, lon: 121.45806, hasResults: False
protocolSection identificationModule nctId: NCT06289790, orgStudyIdInfo id: 16/BW/2023', briefTitle: Erector Spinae Plane (ESP) Block vs Intravenous Lignocaine Infusion in (VATS), statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-02-26, primaryCompletionDateStruct date: 2024-11-07, completionDateStruct date: 2024-11-07, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to compare analgesic efficacy of erector spinae plane (ESP) block vs intravenous lignocaine infusion in video- assisted thoracoscopy (VATS. The main goals are to compare post- operative pain scores and cumulative post- operative opioid doses in both groups, conditionsModule conditions: Thoracic Surgery, Video-Assisted, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, maskingDescription: Patient and nursing staff will be blinded to the performed intervention. PI and performing anaesthesiologist will not be blinded., whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Erector Spinae Plane (ESP) block, interventions name: Lignocaine, outcomesModule primaryOutcomes measure: pain score on numerical rating score, primaryOutcomes measure: cumulative opioid dose, secondaryOutcomes measure: incidence of severe hypotension, secondaryOutcomes measure: incidence of nausea and vomiting, secondaryOutcomes measure: incidence of priuritis, secondaryOutcomes measure: incidence of local anaesthetic systemic toxicity symptoms, secondaryOutcomes measure: intra-operative cumulative opioid dose, secondaryOutcomes measure: time to discharge from hospital, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: National Medical Institute of the Ministry of the Interior and Administration, city: Warsaw, state: Mazowieckie, zip: 02-507, country: Poland, contacts role: CONTACT, phone: 722 14 50, phoneExt: (47), email: anestezja@cskmswia.gov.pl, contacts name: Antoni Okniński, MD, role: PRINCIPAL_INVESTIGATOR, contacts name: Iwona Pikto-Pietkiewicz, MD, role: SUB_INVESTIGATOR, geoPoint lat: 52.22977, lon: 21.01178, hasResults: False
protocolSection identificationModule nctId: NCT06289777, orgStudyIdInfo id: aortic remodeling, briefTitle: Aortic Remodeling After Endovascular Management of Type B Aortic Dissection., statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2026-03-01, completionDateStruct date: 2026-04-01, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: Assess the clinical outcome, morphological changes and behaviour of type B aortic dissection after endovascular repair., conditionsModule conditions: Type B Aortic Dissection, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: TEVAR, outcomesModule primaryOutcomes measure: Analysis of aortic remodeling, primaryOutcomes measure: technical success, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 85 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Faculty of Medicine, city: Asyut, zip: 71515, country: Egypt, geoPoint lat: 27.18096, lon: 31.18368, hasResults: False
protocolSection identificationModule nctId: NCT06289764, orgStudyIdInfo id: 7/02/2024/131, briefTitle: The Effect of Aromatherapy Application With Bergamot and Grapefruit Essential Oils on PMS, acronym: Aromatherapy, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-01, primaryCompletionDateStruct date: 2024-04-20, completionDateStruct date: 2024-05-30, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Esra ÖZER, class: OTHER, collaborators name: KTO Karatay University, descriptionModule briefSummary: Aromatherapy is;the science of using highly concentrated essential oils or essences distilled from plants to take advantage of their therapeutic properties. Essential oils or essences are obtained from various parts of plants (root, leaf, flower, bark, fruit) and used therapeutically for physical and psychological well-being.Premenstrual syndrome (PMS) is a health problem characterized by the periodic occurrence of physical, cognitive, emotional and behavioral symptoms during the luteal phase of the menstrual cycle, ending with the onset of menstruation or with the alleviation of symptoms within a few days after the onset of menstruation. It is reported that approximately 80-95% of women complain of PMS complaints.Although the use of aromatherapy in womens health is widespread, there is no study comparing bergamot and grapefruit essential oils. The aim of this study was to determine the effect of aromatherapy with bergamot and grapefruit essential oils on premenstrual syndrome and menstrual symptoms., conditionsModule conditions: Premenstrual Syndrome-PMS, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 90, type: ESTIMATED, armsInterventionsModule interventions name: Bergamot Essential Oil, interventions name: Grapefruit Essential Oil, interventions name: Sweet almond oil, outcomesModule primaryOutcomes measure: Premenstrual syndrome scale (PMS), secondaryOutcomes measure: Menstrual Symptom Scale, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 35 Years, stdAges: ADULT, contactsLocationsModule locations facility: Ankara Medipol Unıversty, status: RECRUITING, city: Ankara, state: Altındağ, zip: 06000, country: Turkey, contacts name: Esra ÖZER, Asisst. Prof., role: CONTACT, phone: +905433630475, email: esraozellllll@gmail.com, contacts name: Şerife İrem DÖNER, research assistant, role: SUB_INVESTIGATOR, contacts name: Hafize DAĞ TÜZMEN, lecturer, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06289738, orgStudyIdInfo id: ICF in Takayasu Arteritis, briefTitle: ICF in Takayasu Arteritis, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-21, primaryCompletionDateStruct date: 2024-03-20, completionDateStruct date: 2024-03-25, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Pamukkale University, class: OTHER, descriptionModule briefSummary: The aim was to analyze the problem in patients with Takayasu Arteritis based on the International Classification of Functioning, Disability and Health.The sample of our study will consist of individuals between the ages of 18-65 who have been diagnosed with Takayasu Arteritis by rheumatologists and are followed by Pamukkale University Rheumatology Clinic., conditionsModule conditions: Takayasu Arteritis, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 15, type: ESTIMATED, armsInterventionsModule interventions name: ICF, outcomesModule primaryOutcomes measure: 6 open-ended questions, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Elif Gur Kabul, status: RECRUITING, city: Uşak, country: Turkey, contacts name: Elif Gur Kabul, Assistant Professor, role: CONTACT, phone: 00.90.2582964282, phoneExt: 4282, email: elifgur1988@hotmail.com, geoPoint lat: 38.67351, lon: 29.4058, hasResults: False
protocolSection identificationModule nctId: NCT06289725, orgStudyIdInfo id: IRB-VN01002-23932, briefTitle: Impact of Hepatitis B Virus Genotype on Treatment Response in Children With Chronic Hepatitis B, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2026-01-01, completionDateStruct date: 2026-01-01, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-18, sponsorCollaboratorsModule leadSponsor name: Ly Hoa Anh Minh, class: OTHER, descriptionModule briefSummary: The study aimed to evaluate the relationship between hepatitis B virus genotype and treatment response in children with chronic hepatitis B with specific treatment indications. This is a prospective cohort study, with a follow-up period of at least 12 months, conducted at Children's Hospital 1 and City Children's Hospital, Ho Chi Minh City, Vietnam. The patient's blood was taken to be tested for hepatitis B virus genotyping using Sanger sequencing at the Center for Molecular Biomedicine Ho Chi Minh City. The research hypothesis is that genotype is related to treatment response., conditionsModule conditions: Chronic Hepatitis b, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 84, type: ESTIMATED, armsInterventionsModule interventions name: antiviral treatment, outcomesModule primaryOutcomes measure: Serological response for HBeAg, secondaryOutcomes measure: Virological response, otherOutcomes measure: Biochemical response, eligibilityModule sex: ALL, minimumAge: 2 Years, maximumAge: 16 Years, stdAges: CHILD, contactsLocationsModule locations facility: Children's Hospital 1, status: RECRUITING, city: Ho Chi Minh City, country: Vietnam, contacts name: Minh Hoa Anh Ly, role: CONTACT, phone: 0902352622, email: lhaminh.ncs.nhi23@ump.edu.vn, geoPoint lat: 10.82302, lon: 106.62965, locations facility: City Children's Hospital, status: RECRUITING, city: Ho Chi Minh City, country: Vietnam, contacts name: Minh Hoa Anh Ly, role: CONTACT, email: lhaminh.ncs.nhi23@ump.edu.vn, geoPoint lat: 10.82302, lon: 106.62965, hasResults: False
protocolSection identificationModule nctId: NCT06289712, orgStudyIdInfo id: APHP231660, briefTitle: Evaluation of the Ablation of Hepatic Lesions by Electroporation, acronym: EVALHEP, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-11-23, primaryCompletionDateStruct date: 2025-05-23, completionDateStruct date: 2025-05-23, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Assistance Publique - Hôpitaux de Paris, class: OTHER, collaborators name: Inria Team MONC, descriptionModule briefSummary: Irreversible electroporation is a curative treatment for cancerous liver lesions, performed on deep-seated tumors that are not eligible for surgical resection or percutaneous thermal ablation.The EVALHEP project aims to develop criteria for evaluating the effectiveness of the treatment based on imaging, mathematical models, and numerical simulations to assist radiologists who perform these complex procedures., conditionsModule conditions: Liver Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 50, type: ESTIMATED, outcomesModule primaryOutcomes measure: Correlate 3D numerical simulations of the IRE electric field with patient imaging follow-up, secondaryOutcomes measure: Calculation of the tumor coverage rate by the various electric field isolines at different relevant values (for example, three-dimensional isolines between 300 and 700V.cm-1 will be simulated numerically)., secondaryOutcomes measure: Correlation of recovery rate with treatment outcome and local recurrence during clinical follow-up, secondaryOutcomes measure: Identification and assessment of imaging biomarkers (radiomics-based) using numerical simulation and post-therapeutic imaging for treatment response evaluation., secondaryOutcomes measure: Digital resolution of electrical potential and tissue conductivity values from test pulses at the start of the procedure., secondaryOutcomes measure: Develop software solutions potentially usable in real-time and tailored for clinical use., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Service d'imagerie diagnostique et interventionnelle tri-site des HUPSSD, status: RECRUITING, city: Bobigny, zip: 93009, country: France, contacts name: Olivier SUTTER, role: CONTACT, phone: 01 72 40 00 12, email: olivier.sutter@aphp.fr, geoPoint lat: 48.9, lon: 2.45, hasResults: False